Cystic Fibrosis Europe (CFE), Germany

Similar documents
National Center for Tumor Diseases (NCT) Heidelberg, Germany

The Centre for Disease Prevention and Control, Latvia

Central Manchester University Hospitals NHS Foundation Trust, UK

European Society of Cardiology, France

Hospital Universitario de Getafe (Getafe Universitary Hospital), Spain

Hospital Carlos Haya. Malaga, Spain

Ministry for Health, the Elderly and Community Care, Malta

Radboud University Nijmegen Medical Centre, department of Neurology, Netherlands

SERVICIO DE NEUROCIRUGÍA PEDIÁTRICA. HOSPITAL UNIVERSITARIO 12 DE OCTUBRE, Spain

INSTITUTE OF CHILD HEALTH, Greece

RED CELL PATHOLOGY UNIT. HOSPITAL CLINIC-UNIVERSITY OF BARCELONA, Spain

Department of Medical Genetics, Medical School, University of Athens, Greece

Scandinavian Ear Reconstruction Centre, Dept of Plastic and Reconstructive Surgery, SWEDEN

Schoen Kliniken group, Schoen Klinik Hamburg Eilbek, Dept. of neurology and. neurorehabilitation, Germany

Castilla y leon Regional Health Service (Gerencia Regional de Salud de Castilla y León)

Erasmus MC, Center for lysosomal and metabolic diseases, Netherlands

Riga East University hospital stationary Infectology Center of Latvia (RAKUS LIC), Latvia

VSOP, Lupus Netherlands

European Haemophilia Consortium

EUCERD RECOMMENDATIONS QUALITY CRITERIA FOR CENTRES OF EXPERTISE FOR RARE DISEASES IN MEMBER STATES

UNION EUROPÉENNE DES MÉDECINS SPÉCIALISTES

ERN board of Member States

BELGIAN EU PRESIDENCY CONFERENCE ON RHEUMATIC AND MUSCULOSKELETAL DISEASES (RMD)

The following passage wants to illustrate the insufficiencies in CF care the patients, their families and care giver struggle with:

ERN Assessment Manual for Applicants 2. Technical Toolbox for Applicants

WORK PLAN 2017 LAURENCE BALLIEUX NATIONAL FOCAL POINT. 1 EU 3rd HEALTH PROGRAMME

Lessons from the EMA Patient Registries Initiative

European Reference Networks (ERN) Guide for patient advocates

EUCERD RECOMMENDATIONS on RARE DISEASE EUROPEAN REFERENCE NETWORKS (RD ERNS)

ERN Assessment Manual for Applicants

FP7: Marie Curie Actions

Summary of a Survey on the Europe 2020 Flagship Initiative Innovation Union. Executive Summary

ehealth in caring for people with multimorbidity in European countries

Council of the European Union Brussels, 8 September 2014 (OR. en) Mr Uwe CORSEPIUS, Secretary-General of the Council of the European Union

EUREKA and Eurostars: Instruments for international R&D cooperation

A European workforce for call centre services. Construction industry recruits abroad

Document: Report on the work of the High Level Group in 2006

1. Have you or a member of your family had first-hand experience of an adverse event or experienced harm in a healthcare setting in your country?

Assessment of Erasmus+ Sports

Jean Monnet support to associations

European network of paediatric research (EnprEMA)

is a growing initiative of funding institutions fostering collaborative research and innovation with African and European researchers and innovators.

Call for Nominations. CARLOS V European Award

1. Introduction, purpose of this Standard Operating Procedure (SOP)

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL. Report on the interim evaluation of the «Daphne III Programme »

European Solidarity Corps

Delegations will find below the above-mentioned Council conclusions, as endorsed by the Council (General Affairs) on 14 September 2015.

QUICK REFERENCE TO CALDICOTT & THE DATA PROTECTION ACT 1998 PRINCIPLES

Presentation of Interreg Europe

Member webinar: What is an ideal European Reference Network? Matt Johnson, EURORDIS 10 February 2016

1. Introduction, purpose of this Standard Operating Procedure (SOP)

Info Session Webinar Joint Qualifications in Vocational Education and Training Call for proposals EACEA 27/ /10/2017

ECHA Helpdesk Support to National Helpdesks

1. Have you or a member of your family had first-hand experience of an adverse event or experienced harm in a healthcare setting in your country?

Rt hon Jeremy Hunt MP Secretary of State for Health and Social Care. Letter by to Dear Jeremy

Jean Monnet Networks (policy debate with the academic world)

JOINT DECLARATION ON THE PROMOTION AND THE ENFORCEMENT OF CANCER PATIENTS RIGHTS

Current and future standardization issues in the e Health domain: Achieving interoperability. Executive Summary

European Reference Networks. Guidance on the recognition of Healthcare Providers and UK Oversight of Applications

European Reference Networks: strategic value for the Member States. Perspective of France

Presenting the European Investment Advisory Hub Annual Forum of the EUSDR, 2015 Ulm. European Investment Advisory Hub 1

UK Cystic Fibrosis Registry. Data sharing policy

Education and Training Committee, 5 June 2014

Table Of Content. Strengthening voluntary cooperation between Member States to improve the health of EU citizens... 2 Summary... 3 Work Package...

Introduction. 1 About you. Contribution ID: 65cfe814-a0fc-43c ec1e349b48ad Date: 30/08/ :59:32

Regulatory Cooperation in Europe. Natalie McCoy, CEER Secretary General INOGATE Conference - Brussels, 1 February 2013

BUSINESS MISSION INFORMATION GREEN ENERGY TECHNOLOGIES OCTOBER 2017, SINGAPORE PHILIPPINES

Programme Officer International Development

Erasmus+ Programme Jean Monnet Activities. Snejina Nikolova Education, Audiovisual and Culture Executive Agency (EACEA)

Copernicus Incubation Programme

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL

S. Tziaferi. President FOHNEU Assistant Professor in Community Nursing Dep. of Nursing University of Peloponnese

MARKET SCOPING MISSION INFORMATION CONSTRUCTION & BUILDING TECHNOLOGIES NOVEMBER 2018, JAPAN

Do terms like FP6, CORDIS, Specific Programme, Call for

Implementing the 3rd Health Programme. Ingrid Keller Coordinator Health Programme Consumer, Health and Food Executive Agency

ERC Grant Schemes. Horizon 2020 European Union funding for Research & Innovation

Council, 25 September 2014

Guidance for the Applicants: Gilead Sciences Nordic Fellowship Programme 2017

A shared agenda for growth: European Commission Services

Background paper. Cross-border healthcare in the EU

EUCERD Joint Action WP7 Workshop From Centres of Expertise for Rare Diseases to European Reference Networks

2017 Erasmus+ KA1 VET and Adult Education Handbook

Delegations will find attached document EEAS 02246/8/14 REV 8.

JOB VACANCY AT EIT FOOD

STUDENT AGREEMENT For the ERASMUS MUNDUS Joint Master Degree (EMJMD) in Sustainable Tropical Forestry (SUTROFOR)

1. Have you or a member of your family had first-hand experience of an adverse event or experienced harm in a healthcare setting in your country?

Developing a European Registry for Rare Anaemias

2nd European Reference Networks Conference 8-9 October Lisbon, Portugal. A report by: G Porto & F Courtois

EFPIA Code of Practice on relationships between the pharmaceutical industry and patient organisations

116 Help Lines for Rare Diseases

The EU Integration Centre coordinates activities of the Chamber of Commerce and Industry of Serbia (CCIS) in the field of European integration for

EUROPEAN COMMISSION HEALTH AND CONSUMER PROTECTION DG. Directorate C: Public Health and Risk Assessment Unit C2 - Health information

ERASMUS+: OPENING DOORS TO EUROPE

The EUREKA Initiative An Opportunity for Industrial Technology Cooperation between Europe and Japan

MARIE SKŁODOWSKA-CURIE ACTIONS. Individual Fellowships (IF) Date: in 12 pts. David WIZEL Research Executive Agency. 18 March 2016 Split

EFTA SURVEILLANCE AUTHORITY DECISION OF 5 JULY 2006 ON AN AID SCHEME FOR RESEARCH, DEVELOPMENT AND INNOVATION IN THE MARITIME INDUSTRY (NORWAY)

BUSINESS MISSION INFORMATION GREEN ENERGY TECHNOLOGIES 28 OCTOBER 01 NOVEMBER 2018, INDONESIA SINGAPORE

The Seventh Framework Programme for candidate and potential candidate countries European Regional Economic Forum Nova Gorica, 30 May 2007

BUSINESS MISSION INFORMATION GREEN ENERGY TECHNOLOGIES 21 JANUARY 25 JANUARY 2019, KOREA

The Erasmus+ Programme. Katarzyna Żarek, Polish National Agency for Erasmus+, Foundation for the Development of the Education System

Transcription:

Cystic Fibrosis Europe (CFE), Germany 1.1 Please indicate the type of organisation on behalf of which you are responding to this consultation: Please indicate level: 1. Respondent Profile Patient organisation/association European Union umbrella organisation Please indicate Member States representation: Pan European Please indicate for what the administration is responsible: 1.1.1. Other (please specify): 1.2 Please indicate the name of your organisation or centre: Cystic Fibrosis Europe (CFE) 1.3 Please indicate the country where your organsation/centre is located/has its headquarters or main representative office in Europe: 1.4 Please indicate the number of EU Member States and EEA countries (Norway, Iceland, Lichtenstein) and accessing country (Croatia) in which your organisation conducts business/is represented: 1. If need be, can we contact you by e-mail to obtain further information on your submission? 1..1 Please provide an e-mail address where we can contact you: 1.6 Please provide us with a contact person (incl jobtitle and daytime phone number): DE 31 bdembski@muko.info.de Birgit Dembski, health Manager Mukoviszidose e.v. In den Dauen 6 3117 Bonn tel. +49/228 / 98980-0 or +49/30/8400318 bdembskimuko.info office hours: 10.00-14.00 h

1.7 Please provide additional contact details if needed: CFE president Karleen De Rijcke, (CEO) Mucovereniging vzw J. Borlélaan 12 1160 Brussel tel 02/66.33.904 fax 02/67.8.99, karleen@muco.be 2. Involvement of your organisation in the matter of centres of excellence/reference (COE) and healthcare networks in highly specialised healthcare (HSHC). 2.1 How would you describe your organisation's knowledge of CoE and HSHC? Very high 2.1.1 Space for further comments: COE and HSHC with respect to Cystic Fibrosis 2.2. What aspects or domains related to the topic of CoE and HSHC would correspond to your organisation's key knowledge? (cross any that applies) Highly specialised healthcare provision Priorities, description and characteristics of CoE and HSHC Ethical analysis Social aspects Assessment/evaluation/certification of clinical practice and healthcare providers 2.2.1. Space for further comments: 2.3 Is highly specialised healthcare a priority in your organisation's strategies and work plans? Very high 2.3.1 Space for further comments: CFE aims at ensuring that all CF patients have equal access to the best possible CF treatment everywhere in Europe today to enable them to benefit from future disease stopping therapies 2.4. What specific field of healthcare services/specialities are most relevant for your centre/organisation's field of work? Medical speciality Please specify: CF related expert knowledge of care giving team

2.. Has your organisation/centre been directly involved in the design or assessment of professional standards and criteria related with highly specialised healthcare? Frequently 2..1 Please describe your role in such actions/projects: development of national CF quality assessment measures and participation in the European CF registry 2.6. Has your organisation been involved in projects/activities supported by the Commission in relation with HSHC or professional and technical criteria/standards in highly specialised healthcare? 2.7. Do you have concrete examples based on your own organisation's experience or could you provide us with references or links to documents related with professional criteria and standards in highly specialised healthcare/coe or HSHC (e.g. quality criteria, guidelines, consensus documents)? 2.7.1 Space for further comments: All answers in this questionnaire refer to CF specific aspects. CFE has no experiences in an approach comprising rare diseases in general or groups of diseases/conditions 2.13. What is the scope of the network? 2.14. Which kind of network? 2.14.1 Space for further comments: 2.1. Would you be interested in applying to the process to be considered Centre of Excellence of the future European Reference Network? (1 = not interested at all, = very interested) 2.1.1 Space for further comments:

3. Proposed criteria for ERN (scope, general and specific criteria) 3.1 Criteria related with diseases or conditions in order to be considered under the scope of the ERN 3.1.1. Need of highly specialised healthcare 3.1.1.1. Complexity of the diagnosis and treatment 3.1.1.2. High cost of treatment and resources 3 3.1.1.3. Need of advanced/highly specialised medical equipment or infrastructures 3.1.2. Need of particular concentration of expertise and resources 3.1.2.1. Rare expertise/need of concentration of cases 4 3 4 3.1.2.2. Low prevalence/incidence/number of cases 4 3.1.2.3. Evaluated experiences of Member States 3.1.3. Based on high-quality, accessible and cost-effective healthcare 3.1.3.1. Evidence of the safety and favourable risk-benefit analysis 3.1.3.2. Feasibility and evidence of the value and potential positive outcome (clinical) 3.1.4. Do you recommend any additional criteria or option that would effectively address the issue? 3 3

3.1.4.1 Explain your proposal in free text: Any European Reference Center should be patient oriented, and prove this by a written concept, and collaborate with the competent European and national patient organisations 3.1.. Would you prioritise or suggest any concrete disesase or group of diseases to be addressed by the future ERN according to the above criteria? No 3.2. General criteria of the centres wishing to join a European Reference Network 3.2.1. Organisation and management 3.2.2. Patients empowerment and centered care 3.2.3. Patient care, clinical tools and health technology assessment 3.2.4. Quality, patient safety and evaluation framework policies 3.2.. Business continuity, contingency planning and response capacity 3.2.6. Information systems, technology and e-health tools and applications 3.2.7. Overall framework and capacity for research and training 3.2.8. Specific commitment of the management/direction of the centre/hospital to ensure a full and active participation in the ERN 3.2.9. Do you recommend any additional option that would effectively address the issue? 3.2.9.1. Space for further comments: No

3.3. Specific criteria regarding the areas of expertise 3.3.1. Competence, experience and good outcomes and care 3.3.2. Specific resources and organisation: 3.3.2.1. Human resources 3.3.2.2. Team/centre organisation 3.3.2.3. Structural conditions 4 3.3.2.4. Specific equipment 3 3.3.2.. Presence and coordination with other required complementary units or services 3.3.3. Patient care pathways, protocols and clinical guidelines in the field of expertise 3.3.4. External coordination, care management and follow-up of patients 3.3.. Research, training, health technology assessment in the field of expertise 3.3.6. Specific information systems 3 4 3.3.7. Do you recommend any additional criteria or option that would effectively address the issue? 3.3.7.1. Space for further comments: no further comment No